Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |